B4GALT4 Gene - Beta-1,4-Galactosyltransferase 4

Key enzyme in glycoprotein and glycolipid biosynthesis, involved in cell adhesion and signaling.

Gene Information Card

Symbol B4GALT4
Full Name Beta-1,4-Galactosyltransferase 4
Gene Type Protein coding
Chromosomal Location 3q13.32
NCBI Gene ID 8702 ncbi.nlm.nih.gov/gene/8702
Ensembl ID ENSG00000121594
UniProt ID O60513
OMIM ID 604015
HGNC ID HGNC:927
Aliases B4Gal-T4, beta4Gal-T4, GalT4

Description

B4GALT4 encodes a member of the beta-1,4-galactosyltransferase family. This enzyme catalyzes the transfer of galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) residues on glycoproteins and glycolipids, forming the type 2 chain (Galβ1-4GlcNAc). It plays a critical role in the biosynthesis of complex N-glycans and lactosamine repeats, influencing cell adhesion, migration, and signaling.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital disorder of glycosylation type IId (CDG-IId) Deficient B4GALT4 activity leads to incomplete N-glycan synthesis, causing multisystem developmental abnormalities. OMIM #607091; multiple case reports
Colorectal cancer Altered B4GALT4 expression affects tumor cell glycosylation, promoting invasion and metastasis. COSMIC; PMID: 23455423
Breast cancer Upregulation of B4GALT4 correlates with poor prognosis and increased metastatic potential. COSMIC; PMID: 25691885

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Colon 8.3 Low
Breast 6.1 Low
Liver 4.2 Low
Lung 7.8 Low
Kidney 5.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 15.2 Embryonic kidney; high expression
HeLa 9.4 Cervical cancer; moderate expression
MCF7 7.1 Breast cancer; low expression
HCT116 11.3 Colorectal cancer; moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.103C>T (p.Arg35Cys) Missense <0.01% Reduced enzyme activity; associated with CDG-IId
c.487G>A (p.Gly163Arg) Missense <0.01% Loss of function; reported in CDG-IId
c.758T>C (p.Leu253Pro) Missense <0.01% Impaired protein folding; pathogenic in CDG-IId
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Arg35Cys, p.Gly163Arg) reduce or abolish galactosyltransferase activity, leading to CDG-IId.

Gain of Function (GOF)

No gain-of-function mutations reported in B4GALT4.

Dominant Negative (DN)

No dominant-negative mutations described for B4GALT4.

Pathways

Glycosphingolipid biosynthesis - lactoseries (KEGG: hsa00601)
N-Glycan biosynthesis (KEGG: hsa00510)
Metabolism of proteins (Reactome: R-HSA-392499)

Protein Summary

B4GALT4 is a type II transmembrane protein localized to the Golgi apparatus. It contains a short N-terminal cytoplasmic tail, a transmembrane domain, and a large luminal catalytic domain. The enzyme transfers galactose to GlcNAc in a β1-4 linkage, essential for the synthesis of poly-N-acetyllactosamine chains. These chains are critical for cell surface receptor function, including integrins and cadherins, impacting cell adhesion and migration.

Related Products

Product name Cat.No. Species Gene ID
B4GALT4 Knockout HEK293 Cell Line EDJ-KQ6334 Human 8702 Details Get a Quote
B4GALT4 Knockout A-549 Cell Line EDJ-KQ30271 Human 8702 Details Get a Quote
B4GALT4 Knockout HCT 116 Cell Line EDJ-KQ30272 Human 8702 Details Get a Quote
B4GALT4 Knockout HeLa Cell Line EDJ-KQ30273 Human 8702 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: